HUP0300787A2 - Új interferon a sclerosis multiplex kezelésére - Google Patents

Új interferon a sclerosis multiplex kezelésére

Info

Publication number
HUP0300787A2
HUP0300787A2 HU0300787A HUP0300787A HUP0300787A2 HU P0300787 A2 HUP0300787 A2 HU P0300787A2 HU 0300787 A HU0300787 A HU 0300787A HU P0300787 A HUP0300787 A HU P0300787A HU P0300787 A2 HUP0300787 A2 HU P0300787A2
Authority
HU
Hungary
Prior art keywords
treatment
multiple sclerosis
biologically active
interferon
novel interferon
Prior art date
Application number
HU0300787A
Other languages
English (en)
Inventor
Edward M. Croze
Daryl Faulds
T. Charis Wagner
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0300787A2 publication Critical patent/HUP0300787A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A jelen találmány tárgyát olyan új nukleinsavak és polipeptidszekvenciák képezik, amelyek egy interferon-beta-2-t (<IFN-b2<)kódolnak. A találmány tárgyát képezi továbbá egy gyógyászatikompozíció, amely egy gyógyászatilag elfogadható hordozóanyagot ésterápiásan hatékony mennyiségű humán IFN-b2 polipeptidet, annak egybiológiailag aktív fragmensét vagy egy biológiailag aktív származékatartalmazza. A gyógyászati kompozíció humán scleroris multiplexkezelésére alkalmazható. Ó
HU0300787A 2000-06-16 2001-06-18 Új interferon a sclerosis multiplex kezelésére HUP0300787A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21204600P 2000-06-16 2000-06-16
US09/881,050 US20020025304A1 (en) 2000-06-16 2001-06-15 Novel interferon for the treatment of multiple sclerosis
PCT/US2001/041022 WO2001095929A2 (en) 2000-06-16 2001-06-18 Interferon for treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
HUP0300787A2 true HUP0300787A2 (hu) 2003-07-28

Family

ID=26906704

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300787A HUP0300787A2 (hu) 2000-06-16 2001-06-18 Új interferon a sclerosis multiplex kezelésére

Country Status (22)

Country Link
US (1) US20020025304A1 (hu)
EP (1) EP1289541A2 (hu)
JP (1) JP2004505021A (hu)
KR (1) KR20030009529A (hu)
CN (1) CN1436086A (hu)
AU (1) AU2001267099A1 (hu)
BG (1) BG107370A (hu)
BR (1) BR0111852A (hu)
CA (1) CA2413077A1 (hu)
CZ (1) CZ20024094A3 (hu)
EE (1) EE200200693A (hu)
HU (1) HUP0300787A2 (hu)
IL (1) IL152996A0 (hu)
LT (1) LT2002123A (hu)
MX (1) MXPA02012308A (hu)
NO (1) NO20025964L (hu)
NZ (1) NZ522849A (hu)
PL (1) PL359562A1 (hu)
RU (1) RU2003100517A (hu)
SI (1) SI21080A (hu)
SK (1) SK17612002A3 (hu)
WO (1) WO2001095929A2 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314613B2 (en) * 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2504267A1 (en) * 2002-11-18 2004-06-03 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
EP1712992A1 (en) * 2005-04-11 2006-10-18 Sony Ericsson Mobile Communications AB Updating of data instructions
EP2536435B1 (en) 2010-02-18 2017-11-15 Janssen Biotech, Inc. Monkey homolog of human interferon omega
EP3998281A1 (en) 2016-02-05 2022-05-18 Orionis Biosciences BV Cd8 binding agents
KR102642385B1 (ko) 2017-02-06 2024-03-04 오리오니스 바이오사이언시스 엔브이 표적화된 키메라 단백질 및 이의 용도
US10906985B2 (en) 2017-02-06 2021-02-02 Orionis Biosciences, Inc. Targeted engineered interferon and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372206B1 (en) * 1989-03-02 2002-04-16 University Of Florida Orally-administered interferon-TAU compositions and methods
CA2189990A1 (en) * 1994-05-10 1995-11-16 Di-Hwei Hsu Compositions and treatment for multiple sclerosis
JP2001526033A (ja) * 1997-12-08 2001-12-18 ジェネンテク・インコーポレイテッド ヒトインターフェロン−イプシロンというｉ型インターフェロン
IL139933A0 (en) * 1998-05-29 2002-02-10 Biogen Inc A liquid composition containing recombinant interferon-beta
AU6042599A (en) * 1998-09-18 2000-04-10 Zymogenetics Inc. Interferon-epsilon
AU2001255380A1 (en) * 2000-04-14 2001-10-30 Zymogenetics Inc. Human interferon, zinf2

Also Published As

Publication number Publication date
NO20025964L (no) 2003-02-14
JP2004505021A (ja) 2004-02-19
NO20025964D0 (no) 2002-12-12
SI21080A (sl) 2003-06-30
MXPA02012308A (es) 2003-04-25
BG107370A (en) 2003-11-28
BR0111852A (pt) 2003-05-20
CA2413077A1 (en) 2001-12-20
SK17612002A3 (sk) 2003-08-05
WO2001095929A3 (en) 2002-10-10
KR20030009529A (ko) 2003-01-29
WO2001095929A2 (en) 2001-12-20
CZ20024094A3 (cs) 2003-05-14
RU2003100517A (ru) 2004-06-27
CN1436086A (zh) 2003-08-13
PL359562A1 (en) 2004-08-23
IL152996A0 (en) 2003-06-24
LT2002123A (en) 2003-06-25
EE200200693A (et) 2004-06-15
NZ522849A (en) 2004-05-28
EP1289541A2 (en) 2003-03-12
US20020025304A1 (en) 2002-02-28
AU2001267099A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
AU3368497A (en) Human dnase i hyperactive variants
ATE262914T1 (de) Entzündungsproteine aus makrophagen mip-3, mip-4 und mip-1gamma
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
DE1033998T1 (de) Methode zur unterdrückung von beta-amyloid-verwandten veränderungen in alzheimer
CA2273852A1 (en) Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
HUP0300814A2 (hu) Peptidszelekciós módszer
HK1030157A1 (en) Use of consensus interferon and compositions comprising consensus interferon.
GB0100551D0 (en) Protein
HUP0300787A2 (hu) Új interferon a sclerosis multiplex kezelésére
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
MA27474A1 (fr) Vaccin
ATE371737T1 (de) Proteaseresistente flint-analoge
HUP9801075A2 (hu) Kombinált állandó dózisú angiotenzint átalakító enzim inhibítor kalciumcsatorna-antagonista, eljárás ennek előállítására, valamint alkalmazása szív- és érrendszeri betegségek kezelésében
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
BG101846A (en) HUMAN DNase I VARIANTS
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
MX9706429A (es) Variantes de dnasa i humana.
UA34265A (uk) Паста для лікування захворювань тканин пародонту
DK1379253T3 (da) Fremgangsmåde til fremstilling og anvendelse af farmaceutiske formuleringer omfattende 7alfa, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-on og 17-estere heraf